Bridgewater Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14M | Sell |
|
|||||
|
2025
Q2 | $34.8M | Buy |
|
|||||
|
2025
Q1 | $4.53M | Sell |
|
|||||
|
2024
Q4 | $8.02M | Sell |
|
|||||
|
2024
Q3 | $10.9M | Sell |
|
|||||
|
2024
Q2 | $48M | Buy |
|
|||||
|
2024
Q1 | $46.4M | Sell |
|
|||||
|
2023
Q4 | $68.9M | Sell |
|
|||||
|
2023
Q3 | $73.1M | Buy |
|
|||||
|
2023
Q2 | $73.8M | Sell |
|
|||||
|
2023
Q1 | $78M | Buy |
|
|||||
|
2022
Q4 | $67.6M | Sell |
|
|||||
|
2022
Q3 | $93.4M | Buy |
|
|||||
|
2022
Q2 | $94.6M | Sell |
|
|||||
|
2022
Q1 | $134M | Buy |
|
|||||
|
2021
Q4 | $105M | Buy |
|
|||||
|
2021
Q3 | $78.1M | Sell |
|
|||||
|
2021
Q2 | $72.2M | Buy |
|
|||||
|
2021
Q1 | $32.6M | Buy |
|
|||||
|
2020
Q4 | $28.6M | Buy |
|
|||||
|
2020
Q3 | $11.5M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $464K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2.11M | Buy |
|
|||||
|
2019
Q2 | $1.38M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.67M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $3.7M | Sell |
|
|||||
|
2017
Q3 | $13.1M | Buy |
|
|||||
|
2017
Q2 | $4.81M | Sell |
|
|||||
|
2017
Q1 | $4.27M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $5.43M | Buy |
|
|||||
|
2016
Q2 | $3.37M | Buy |
|
|||||
|
2016
Q1 | $1.66M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $4.55M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $1.79M | Buy |
|